Moderna pharmaceutical company revealed, this Thursday, to have agreed with the European Commission to postpone the delivery of some batches of vaccines against Covid-19 to the European Union (EU). At issue is the falling demand for vaccines against the SARS-CoV-2 virus.

According to a statement from the European Commission, quoted by the Reuters news agency, deliveries to member states scheduled for the second quarter of 2022 will take place at the end of the year or early 2023.

Under this new agreement with Moderna, EU countries will also have access to the vaccine that offers protection against Omicron variant and influenza, if it is proven to be effective.

The European bloc also announced a similar agreement with the Pfizer/BioNTech consortium to delay vaccine delivery by three.

The agreement helps to "optimize supply arrangements and align them with current levels of demand in our member states," said Stella Kyriakides, European Commissioner for Health.

Source: Lusa